Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in low & middle-income countries

An international registry.

Griffee MJ, Bozza PT, Reyes LF, Eddington DP, Rosenberger D, Merson L, Citarella BW, Fanning JP, Alexander PMA, Fraser J, Dalton H, Cho SM; ISARIC Clinical Characterisation Group Res Pract Thromb Haemost DOI: 10.1016/j.rpth.2023.102142

Background: COVID-19 has been associated with a broad range of thromboembolic, ischemic, and hemorrhagic complications (coagulopathy complications). Most studies have focused on patients with severe disease from high-income countries (HICs).

Previous
Previous

Advances in cardiac machine perfusion: Exceeding 8 hours from procurement to implant without requiring ECMO

Next
Next

Improving Trendelenburg position effectiveness by varying cardiopulmonary bypass flow